Correlation Between Atara Biotherapeutics and Axsome Therapeutics
Can any of the company-specific risk be diversified away by investing in both Atara Biotherapeutics and Axsome Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atara Biotherapeutics and Axsome Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atara Biotherapeutics and Axsome Therapeutics, you can compare the effects of market volatilities on Atara Biotherapeutics and Axsome Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atara Biotherapeutics with a short position of Axsome Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atara Biotherapeutics and Axsome Therapeutics.
Diversification Opportunities for Atara Biotherapeutics and Axsome Therapeutics
-0.71 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Atara and Axsome is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Atara Biotherapeutics and Axsome Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Axsome Therapeutics and Atara Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atara Biotherapeutics are associated (or correlated) with Axsome Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Axsome Therapeutics has no effect on the direction of Atara Biotherapeutics i.e., Atara Biotherapeutics and Axsome Therapeutics go up and down completely randomly.
Pair Corralation between Atara Biotherapeutics and Axsome Therapeutics
Given the investment horizon of 90 days Atara Biotherapeutics is expected to under-perform the Axsome Therapeutics. In addition to that, Atara Biotherapeutics is 2.13 times more volatile than Axsome Therapeutics. It trades about -0.17 of its total potential returns per unit of risk. Axsome Therapeutics is currently generating about 0.23 per unit of volatility. If you would invest 8,513 in Axsome Therapeutics on December 5, 2024 and sell it today you would earn a total of 4,127 from holding Axsome Therapeutics or generate 48.48% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 97.5% |
Values | Daily Returns |
Atara Biotherapeutics vs. Axsome Therapeutics
Performance |
Timeline |
Atara Biotherapeutics |
Axsome Therapeutics |
Atara Biotherapeutics and Axsome Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Atara Biotherapeutics and Axsome Therapeutics
The main advantage of trading using opposite Atara Biotherapeutics and Axsome Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atara Biotherapeutics position performs unexpectedly, Axsome Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axsome Therapeutics will offset losses from the drop in Axsome Therapeutics' long position.Atara Biotherapeutics vs. Fate Therapeutics | Atara Biotherapeutics vs. Sana Biotechnology | Atara Biotherapeutics vs. Caribou Biosciences | Atara Biotherapeutics vs. Arcus Biosciences |
Axsome Therapeutics vs. Incyte | Axsome Therapeutics vs. Sarepta Therapeutics | Axsome Therapeutics vs. ACADIA Pharmaceuticals | Axsome Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements |